Poster Presentation Australian Society for Microbiology Annual Scientific Meeting 2018

Engineering a bacterial toxin for improved function as a N-glycolylneuraminic acid specific lectin (#368)

Lucy K Shewell 1 , Jing Wang 1 , Adrienne W Paton 2 , James C Paton 2 , Christopher J Day 1 , Michael Jennings 1
  1. Institute for Glycomics, Griffith University, GOLD COAST, QLD, Australia
  2. Research Centre for Infectious Diseases, University of Adelaide, Adelaide, SA, Australia

The B subunit of the subtilase cytotoxin (SubB) produced by Shiga toxigenic Escherichia coli (STEC) recognises N-glycolylneuraminic acid (Neu5Gc) containing glycans, the most prominent form of aberrant glycosylation in human cancers. We have previously engineered SubB by construction of a SubB∆S106/∆T107 mutant (SubB2M) for greater specificity and enhanced recognition of Neu5Gc containing glycans. In this study, we further explore the utility of SubB2M as a Neu5Gc lectin by showing its improved specificity and recognition for Neu5Gc containing glycans over the wild-type SubB protein and an anti-Neu5Gc IgY antibody in a N-acetylneuraminic acid (Neu5Ac)/Neu5Gc glycan array and by surface plasmon resonance. Far-western blot analysis showed that SubB2M preferentially binds to bovine serum glycoproteins over human serum glycoproteins. SubB2M was also able to detect Neu5Gc containing bovine glycoproteins spiked into normal human serum with greater sensitivity than the wild-type SubB and the anti-Neu5Gc IgY antibody. These results suggest that SubB2M will be a useful tool for the testing of serum and other bodily fluids for cancer diagnosis and prognosis.